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Ocular complicationsAbstract Introduction: Sleep disorders are common and obstructive sleep apnea hypopnea syn-
drome (OSAHS) is the commonest. OSAHS is not commonly diagnosed by the ophthalmologist,
but it has many systemic and ocular complications.
Aim of the work: The aim of this study was to detect the effect of sleep related breathing disor-
ders on ocular function.
Patients and methods: Thirty patients with OSAHS were enrolled after obtaining informed con-
sents. Patients were subjected to full history taking, Epworth sleepiness scale, anthropometric data,
Mallampati score, clinical apnea score, sleep study and complete ocular examination.
Results: 4 patients had mild OSAHS (13.33%), 12 patients had moderate OSAHS (40%) and 14
patients had severe OSAHS (46.67%) two of them had sleep hypoventilation. 4 patients were free
from any ocular manifestations. In 26 patients one or more of the following ocular ﬁndings were
found: ﬂoppy eyelid syndrome (FES) was detected in 3 (10%) patients, glaucoma was diagnosed
in 5 (16.67%) patients, senile cataract was found in 3 (10%) patients, nonarteritic anterior ischemic
optic neuropathy (NAION) was detected in 4 (13.33%) patients, papilledema was diagnosed in 3
(10%) patients and 18 (60%) patients had dry eye manifestations.
In conclusion: The increased prevalence of ocular symptoms and signs in patients with OSAHS
indicates a need to increase awareness and establish close collaboration with the sleep physicians
with clear pathways for review of OSAHS patients by the ophthalmic services. We should study
the effect of treatment of OSAHS on the ocular manifestations.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.Introduction
Sleep disorders are common and obstructive sleep apnea hypo-
pnea syndrome (OSAHS) is the commonest. Approximately
90% of patients who have obesity hypoventilation syndrome
(OHS) exhibit sleep-disordered breathing consisting of
obstructive apneas and hypopneas (apnea-hypopnea index
664 E.E. Mohamed, T.H. Massoud[AHI]P 5/h), whereas the remaining 10% of patients who
have OHS have an AHI less than 5/h. OSAHS is a potentially
serious sleep disorder characterized by recurrent episodes of
breathing cessation during sleep secondary to upper airway
collapse. Complete apnea or partial hypopnea episodes can
last from 10 s or more and may occur up to hundreds of times
nightly. It is often accompanied with swings in heart rate, a de-
crease in oxygen saturation, and brief electroencephalogram
arousals. Sleep apnea is a disorder not commonly diagnosed
by the ophthalmologist, but it has many systemic and ocular
complications [1].
Floppy eyelid syndrome (FES), ﬁrst described in 1981 by
Culbertson and Ostler, is characterized by elastic upper eyelids
that are easily everted with minimal lateral traction, associated
with a papillary conjunctivitis of the upper palpebral conjunc-
tiva. A weak tarsal plate allows the lid to fold upon itself with
ease [2]. Obesity may be a confounding factor in the associa-
tion of FES and OSAHS as many patients with OSAHS suffer
from obesity [3].
Both normal tension and primary open-angle glaucoma
have been associated with sleep apnea. Theories of mechanism
include: (1) impaired optic nerve head blood ﬂow secondary to
episodes of apnea, (2) optic nerve vascular dysregulation sec-
ondary to arteriosclerosis and variations in arterial blood pres-
sure, and (3) episodes of hypoxia. As ocular blood ﬂow has
been suggested as a mechanism in glaucoma [4].
Non-Arteritic Ischemic Optic Neuropathy (NAION), an
ischemic event may be secondary to impaired optic nerve head
blood ﬂow autoregulation from apnea. Optic nerve vascular
dysregulation may also be a result of variations in arterial
blood pressure seen in OSA, which may be due to an imbal-
ance between nitric oxide and endothelin. Additionally, direct
damage by periods of hypoxia likely plays a role [5,6].
Bucci and Krohel ﬁrst reported a case of papilledema in a
patient with OSAHS in 1988, who had surgical treatment cor-
recting his OSAHS which resolved his papilledema [7]. Since,
then, numerous cases have been reported of patients found
to have papilledema and idiopathic intracranial hypertension.
Many of these patients, however, have had normal opening
pressures on lumbar puncture. Correction of their OSAHS
with continuous positive airway pressure (CPAP) treatment
had resolved the papilledema [8].
Patients with sleep apnea have increased levels of circulat-
ing epinephrine and norepinephrine. With elevated levels of
catecholamines, OSAHS has been hypothesized to be a direct
risk factor for central serous chorioretinopathy (CSCR) [9].
Retinal vein occlusions may be associated with OSAHS as
theymay be secondary to a slow-down of blood ﬂow circulation
secondary to hypoxemia and elevated nocturnal intracranial
pressure. Strictly acting on the retinal microcirculation, OSAHS
may directly have a causal effect on retinal vein occlusions [10].
CPAP administered through a nasal or face mask has re-
mained the mainstay of treatment in OSAHS since its advent
in the 1980s. Non-speciﬁc behavioral measures such as weight
loss, avoiding smoking, alcohol, and sedatives can impact on
symptoms’ control, but are inadequate for moderate to severe
disease. Effect of these treatment measures on the ocular man-
ifestations is less well documented, as most literature docu-
ments ocular changes at the time of diagnosis of the sleep
disorder [1,5]. Isolated case reports in the literature have sug-
gested reversal of symptoms of FES accompanied with signif-
icant weight loss [11] and initiation of CPAP [12]. Morerecently, effects of CPAP on intraocular pressure and perfor-
mance in visual ﬁeld (VF) testing have been reported [13,14].
In addition, leaking from the masks used with CPAP can cause
ocular irritation and even induce conjunctivitis [15,16].
Aim of the work
The aim of this study was to detect the effect of sleep related
breathing disorders on ocular function.
Subjects and methods
Study population and subjects
Thirty patients with documented obstructive sleep apnea
hypopnea syndrome, admitted to the chest department, Alex-
andria main university hospital were enrolled after obtaining
informed consents.
Study measurements
All patients were subjected to the following:
1. Full history taking including age, sex, smoking index and
history of other diseases.
2. Epworth sleepiness scale [17].
3. Anthropometric data including: Body mass index (BMI),
neck circumference (NC), and waist/hip ratio. BMI derived
from the weight and height using the formula (Quetelet’s
index = weight (kg)/height (m)2).
4. Thorough clinical examination including: Mallampati
score, general examination and local chest examination to
exclude other chest diseases and exacerbation.
5. Clinical apnea score [18].
6. Sleep study: all patients were subjected to overnight poly-
somnogram using somoscreen plus RC combi 39 including
the following channels:
 Flow (Cannula &/or Thermistor).
 Snore (Cannula &/or Mic).
 Thoracic Effort (RIP Option).
 Abdominal Effort (RIP Option).
 Oxygen saturation (Spo2).
 Plethysmogram.
 Pulse Rate.
 Electrocardiogram (ECG).
 Obstruction.
 CPAP/BiPAP Pressure.
 Periodic leg movement (PLM).
 Electroencephalogram (EEG) (Fig. 1).
Apneas and hypopneas were scored using criteria estab-
lished by the American Academy of Sleep Medicine (2012) [19].
Score a respiratory event in adults as an apnea if both of the
following were met:
a. There is a drop in the peak signal excursion byP90% of
pre-event baseline using an oronasal thermal sensor.
b. The duration of theP90%drop in sensor signal isP10 s.
In 2012 the American Academy of Sleep Medicine (AASM)
Sleep Apnea Deﬁnitions Task Force reviewed the rules for
Figure 1 Somoscreen plus RC combi 39 device applied to the patient.
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hypopnea.
Score a respiratory event as a hypopnea if all of the follow-
ing were met:
a. The peak signal excursions drop by P30% of pre-event
baseline using nasal pressure.
b. The duration of the P30% drop in signal excursions is
P10 s.
c. There isP3% oxygen desaturation from pre-event base-
line or the event is associated with an arousal.
The following parameters were calculated:
 Apnea hypopnea index (AHI): AHI is the total number of
apnea and/or hypopnea per hour of sleep.
 Baseline O2 saturation: it is the oxygen saturation at the
start of the study.
 Mean O2 saturation: it is the mean value of oxygen satura-
tion during the total sleep time.
 Minimal O2 saturation: it is the lowest oxygen saturation
recorded during the total sleep time.
 Oxygen desaturation index (ODI): it is the total number of
desaturations by at least 3% from the previous tracing per
hour of sleep and it is calculated by dividing the total num-
ber of desaturations by at least 3% from the previous trac-
ing over the total sleep time (hrs).
 T90%: it is the percentage of sleep time with oxygen satura-
tion below 90%.
 Hypoventilation: We examined the overnight oximetric
tracing to assess if there was hypoventilation. Hypoventila-
tion was considered when there was a sustained decrease ofSpO2 as detected by the oximeter (sagging of the oximetric
tracing). Oximeter is a reliable tool to detect hypoventila-
tion whenever the patient is on room air and not receiving
any supplemental oxygen.
After the sleep study all patients were subjected to CPAP as
a therapy to be titrated by a follow up study.
7. Full ophthalmological assessment through:
 Ophthalmic history taking (patients suffering from any
previous ocular problems were excluded from the study).
 Uncorrected visual acuity (UCVA) measurement.
 Manifest refraction (MR).
 Best corrected visual acuity (BCVA) measurement.
 Slit lamp biomicroscopic examination of the anterior s-
egment of the eye and the ocular surface.
 Dilated fundus examination for assessment of the condi-
tion of the retina and the optic nerve head.
 Intraocular pressure measurement by applanation
tonometry.
 The following investigations were performed when
needed: Fluorescein angiography.
 Visual ﬁeld assessment.
 Optical coherence tomography.Statistical analysis
Statistical analysis was performed with Sigma Stat 2.0 (Systat
Software Inc., Point Richmond, Calif) and SPSS 14 (SPSS,
Chicago, Ill) for Windows.
Figure 2 Floppy eye lids.
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This study was carried on 30 patients subjected to the sleep
study; 19 males (63.33%) and 11 females (36.67%). The age
ranged from 36 to 75 years with a mean ± SD value of
54.6 ± 9.3 years, 18 patients (60%) were current or former
smokers and the pack year index had a mean ± SD value of
36.1 ± 20.32, 20 patients (66.67%) were diabetic and 15 pa-
tients (50%) had history of hypertension. Epworth sleepiness
scale (ESS) showed that 24 patients out of 30 (80%) had
hypersomnolence with an ESS of 10/24 or more.
The BMI of the patients ranged from 26.34 to 55.53 kg/m2
with a mean ± SD value of 33.25 ± 6.71 kg/m2, 22 of them
(73.33%) were obese with BMI P30 kg/m2 and 8 of them
(26.67%) were overweight with BMIP 25–29.9 kg/m2. The
neck circumference (NC) ranged from 36 to 43 cm with a
mean ± SD value of 38.1 ± 2.87 cm. The waist/hip ratio ran-
ged from 0.89 to 1.12 with a mean ± SD value of 1 ± 0.05.
The Mallampati score ranged from 1 to 4 with a
mean ± SD value of 2.7 ± 0.87. The clinical apnea score ran-
ged from 0 to 5 with a mean ± SD value of 1.53 ± 1.22.
Table (1) showed the polysomnographic respiratory data of
the studied patients, 4 patients had mild OSAHS (13.33%), 12
patients had moderate OSAHS (40%) and 14 patients had se-
vere OSAHS (46.67%) two of them had sleep hypoventilation.
Table (2) showed the ocular ﬁndings of the studied patients;
4 patients were free from any ocular manifestations (patients
with mild OSAHS). In 26 patients (patients with moderate
and severe OSAHS) one or more of the following ﬁndings were
found: ﬂoppy eyelid syndrome (FES) was detected in 3 (10%)Table 1 Data of the sleep study.
The sleep parameters Mean ± SD
Apnea/hypopnea index 65 ± 29.75/h
Basal oxygen saturation 91.73 ± 4.90%
Mean oxygen saturation 83.95 ± 7.59%
Minimal oxygen saturation 61.62 ± 18.74%
Oxygen desaturation index (ODI) 49.78 ± 22.32/h
T90% 3.46 ± 1.21% of the total
sleep time
Table 2 Data of the ocular ﬁndings.
The ocular ﬁndings Number and
percentage of
patients
Floppy eyelid syndrome (FES) (n= 3) 10%
Glaucoma (n= 5) 16.67%
Senile cataract (n= 3) 10%
Non-arteritic ischemic optic neuropathy
(NAION)
(n= 4) 13.33%
Papilledema (n= 3) 10%
Dry eye manifestations [in the form of
conjunctival hyperaemia, lid parallel
conjunctival folds and conjunctivo-chalasis
(redundant conjunctiva)]
(n= 18) 60%
Free from any ocular manifestations (n= 4) 13.33%
Figure 3 Glaucomatous optic disc cupping.patients, glaucoma was diagnosed in 5 (16.67%) patients, se-
nile cataract was found in 3 (10%) patients, nonarteritic ante-
rior ischemic optic neuropathy (NAION) was detected in 4
(13.33%) patients, papilledema was diagnosed in 3 (10%) pa-
tients and 18 (60%) patients had dry eye manifestations [in the
form of conjunctival hyperaemia, lid parallel conjunctival
folds and conjunctivo-chalasis (redundant conjunctiva)]
(Figs. 2–5).
Figure 4 Conjunctival Hyperaemia.
Figure 5 Redundant Conjunctiva.
Effect of sleep related breathing disorders onocular function 667Discussion
OSAHS is associated with a number of serious systemic dis-
eases and also several eye disorders including ﬂoppy eyelid syn-
drome, optic neuropathy, glaucoma, anterior ischemic optic
neuropathy and papilledema secondary to raised intracranial
pressure. Treatment of OSAHS may help ﬂoppy eyelid syn-
drome, stop progression of associated glaucoma, and reduce
intracranial pressure in patients with associated papilledema.
The diagnosis of OSAHS can only be made with formal sleep
studies, but asking a small number of appropriate questions
will help screen those patients who should be referred to sleep
studies [5].
In this study, all patients with mild OSAHS were free from
any ocular manifestations and ocular manifestations existed in
patients with moderate and severe OSAHS. Floppy eyelid syn-
drome (FES) was detected in 3 (10%) patients with OSAHS.
FFS is one of the ocular disorders that have been associated
with OSAHS. It is characterized by rubbery, redundant upper
eyelid tissue and papillary conjunctivitis, and is seen most com-
monly in obese middle-aged men. The affected eyelid may cor-
respond to the side on which the patient prefers to sleep. The
etiology is uncertain, but current theories include an upregula-
tion of elastin-degrading matrix metalloproteinases possibly
caused by direct eyelid trauma, ischemia–reperfusion injurydue to pressure placed on the eyelid, or low arterial oxygen
tension during sleep; again obesity is a risk factor for both
FES and OSAHS. When FES is severe, the eyelid may sponta-
neously evert during sleep and rub on the patient’s pillow,
causing an acute exacerbation of mechanically induced con-
junctivitis. The prevalence of OSAHS in patients with FES
has been reported to be as high as 90 percent; only 2–5 percent
of patients with OSAHS may have FES. Thus, it is impractical
to screen all patients with OSAHS for FES. However, all
patients with FES who do not have an established diagnosis
of OSAHS should have a thorough sleep history taken and,
when appropriate, should be referred to sleep evaluation
including polysomnography. Patients with FES and OSAHS
who are already being treated with CPAP need to have their
masks properly ﬁtted to avoid additional eye injury due to mis-
directed air further drying out the eyes [20].
The range of reported rates of FES prevalence (2.3–32%) in
different series of OSAHS patients includes Karger et al. [21],
1/44, 2.3%; Roberts et al. [22], 1/46, 2.2%; McNab [23], 3/20,
15%; and in 1999 Mojon et al. [24], found 14/44 (32%) pa-
tients with OSAHS had FES. All, but one of the studies (i.e.
Robert et al. [22]), were conducted at the time of initial referral
to OSAHS before initiation of CPAP.
In the current study, glaucoma was diagnosed in 5
(16.67%) patients; the link between glaucoma and OSAHS is
controversial. There was a high prevalence of both primary
open-angle glaucoma and normal-tension glaucoma among
patients with OSAH. Several studies have identiﬁed OSAHS
in patients with glaucomatous optic disc cupping and associ-
ated visual ﬁeld defects who do not respond to medical or sur-
gical intraocular pressure lowering treatments, but whose
visual ﬁelds stabilize when treated with CPAP [4,5]. One
Chinese study showed that patients with OSAHS were four
times more likely to have glaucomatous optic disc changes
and visual ﬁeld defects than age-matched controls [25].
Another study by Mojon et al. [4] reported the prevalence
of glaucoma among 69 patients with obstructive sleep apnea
to be 7.2%. Waller et al. [26] criticized the design of many
studies looking for a relationship between glaucoma and
obstructive sleep apnea. Their criticisms included ﬂawed from
reliance on reported symptoms, lack of properly matched con-
trols, etc. In Waller et al’s study of 100 patients with obstruc-
tive sleep apnea, they found the prevalence of glaucoma to be
27%. Based on Mojon and Waller’s reports, the most cautious
approach would be to have all obstructive sleep apnea patients
screened for glaucoma, and OSAHS should be considered as a
possibility in all patients with primary open angle or normal
tension glaucoma.
In the present study, nonarteritic anterior ischemic optic
neuropathy (NAION) was detected in 4 (13.33%) patients.
The prevalence of obstructive sleep apnea among those with
NAION has been reported at 71–89%. The prevalence of
NAION among those with OSA has not been studied. The
possible causal relationship between OSAHS and NAION is
very similar to their list of possible mechanisms relating glau-
coma and obstructive sleep apnea [5].
In 2002 Mojon et al. [27] proposed mechanisms for nonarte-
ritic anterior ischemic optic neuropathy in patients with
obstructive sleep apnea include the following: obstructive sleep
apnea results in impaired vascular autoregulation of the optic
nerve’s circulation; obstructive sleep apnea induces arterioscle-
rosis and arterial hypertension, which in turn induce optic nerve
668 E.E. Mohamed, T.H. Massoudvascular ‘‘dysregulation’’; repetitive hypoxia directly damages
the optic nerve; obstructive sleep apnea causes an imbalance be-
tween nitric oxide and endothelin (vasodilatory and vasocon-
strictive factors). Palombi et al. [28] had noted an even higher
prevalence in their study where 89% of patients with NAION
had sleep apnea. It has been suggested that patients with
NAION can be questioned about their sleep habits. One re-
search group that did this elicited a history of OSAHS 2.5 times
more often in patients with NAION than in controls [29].
In this study, papilledema was diagnosed in 3 (10%)
patients. Papilledema also associated with OSAHS, is thought
to be caused by nocturnal increase in intracranial pressure.
Potential mechanisms include raised venous pressure due to
forced inspiration against a closed airway or hypoxia-induced
cerebral venous dilation. When neuroimaging is normal, a
careful sleep history in a patient with papilledema is critical
in order to determine whether OSAHS is a causative factor.
In such patients, treatment of the OSAHS has been shown
to improve, resolve or halt the progression of papilledema [5].
Sugita et al. [30] did 24-h monitoring of intracranial pres-
sure in patients with obstructive sleep apnea. Sugita et al. found
that intracranial pressure increases during sleep in association
with apnea, and the longer the duration of the apnea, the great-
er the increase in ICP. Episodes of apnea would ‘‘precede and
accompany’’ episodes of intracranial pressure increase. None
of their patients had increased intracranial in the daytime.
Sugita et al. hypothesized that the dull morning headaches that
are common in those with obstructive sleep apnea may be
attributable to ceresbrospinal ﬂuid pressure increase during
sleep. Waller et al. [26] said that some patients with more severe
obstructive sleep apnea have low blood oxygen levels and in-
creased intracranial pressure even in the daytime.
Purvin et al. [31] studied four patients with obstructive sleep
apnea and papilledema. Purvin et al. hypothesized that low
blood oxygen and high CO2 would cause cerebral vasodilation,
which in turn would result in transient increase in intracranial
pressure.
In the present study, 18 (60%) patients had dry eye mani-
festations in the form of chronic conjunctival hyperaemia, lid
parallel conjunctival folds and conjunctivo-chalasis (redun-
dant conjunctiva). A variety of common ocular surface prob-
lems have been associated with CPAP use which delivers air
under pressure to the nose.
Leaks from the CPAP mask hitting the face and eyes are
the main cause for dry eyes. Fixing these leaks can eliminate
these dry eyes. When the patient starts to put the CPAP mask
on, it is very important to let the mask loose on the face and
then start the CPAP machine. In this way, the mask cushion
will ﬁll up with air. Then the patient can tighten the straps
on the face. If the leaks could not stop, we should change
the mask or use special goggles to protect the eyes from the
air blowing in them.
Some patients with sleep apnea have problems with the tear
ducts, sinuses and eyelids. The air that enters in the airways
from the CPAP could also enter through these ducts to the
eyes. If the air from the CPAP machine is also humidiﬁed,
the liquid may accumulate under the skin around the eyes [24].
During the night, air may escape from around the mask and
blow onto the eyes resulting in morning sensations of dry, irri-
tated eyes and conjunctivitis, alternatively air may ﬁnd its way
up through the nasolacrimal duct, and cause similar problems.
There are a series of valves that guard against retrograde ﬂowup the duct, but in many people these valves are not totally
effective in preventing retrograde ﬂow [15]. Therefore the
investigators try to ﬁnd other methods of treatment of OSAHS
and their ﬁndings establish proof-of-principle that targeted
blockade of certain potassium channels at the hypoglossal mo-
tor pool is an effective strategy for reversing upper airway
hypotonia and causing sustained reactivation of genioglossus
throughout non rapid eye movement and rapid eye movement
sleep. These ﬁndings identify an important new direction for
translational approaches to the pharmacological treatment of
obstructive sleep apnea [32].
In conclusion, the increased prevalence of ocular symptoms
and signs in patients with OSAHS indicates a need to increase
awareness and establish close collaboration with the sleep phy-
sicians with clear pathways for review of OSAHS patients by
the ophthalmic services. We should study the effect of treat-
ment of OSAHS with CPAP on the ocular manifestations.
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